Results

Total Results: 2,065 records

Showing results for "years".

  1. effectivehealthcare.ahrq.gov/sites/default/files/cer-231-dementia-interventions-evidence-summary_0.pdf
    August 01, 2020 - or complex presentations of dementias. 2 affects about 5 million U.S. adults 65 years … of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >65 years
  2. effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - system is intended to identify interventions that purport to address an unmet need and are up to 7 years … out on the horizon and then to follow them for up to 2 years after initial entry into the health care … Topics eligible for inclusion are those interventions expected to be within 0–4 years of potential … ES-3 Although AD is potentially fatal, patients can live as long as 20 years after diagnosis and often … The anticipated doubling of the number of people aged 65 years and older by 2040 portends an increase
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
    September 20, 2013 - Food and Drug Administration (FDA) to treat irritability in children 5 to 16 years of age with ASD.48 … adaptive behavior when the intervention was delivered over substantial intervals of time (i.e., 1–2 years … Question 1 Among children ages 0–12 years who have ASD, what are the short- and long-term effects of … Question 2 Among children ages 0–12 years, what are the modifiers of outcome for different treatments … The population of interest is patients 0–12 years diagnosed with ASD.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
    September 14, 2016 - Globally, asthma ranks 14th based on the burden of disease, as measured by disability adjusted life years … not well defined, though, the maintenance dose is typically given once or twice monthly for 3 to 5 years … Through the years, various chemical modifications of allergens have been attempted to enhance efficacy … For studies with pediatric patients, we will present results, where possible, by the categories: 0-4 years … old, 5-11 years old and older than 12 years old1 o Grouping by asthma severity and asthma control
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
    May 01, 2015 - Recognition of potential benefits of breastfeeding in recent years has resulted in a renewed interest … What are the benefits of various treatments for ankyloglossia in children through 18 years of age intended … Analytic framework for ankyloglossia in infants and children through18 years of age Children with … ankyloglossia or with ankyloglossia tight labial frenula ages 0 to 18 years Harms (Key Questions … = 18; control group).16 The frenotomy group performed better than the no-frenotomy group at age 3 years
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
    March 11, 2010 - Introduction The USPSTF and many other organizations suggest starting screening at age 40 years of age … We are aware that 2 years is commonly suggested in the literature; however, requiring 2 years would … certainly comes from pooling data from studies that may have differed in many small details such as years … Results p. 42 “within the last five years” is too vague. … The authors should specify the years to aid readers using this report a decade later.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0594-131115.pdf
    March 13, 2013 - )  Children with neurodevelopmental delays during their early years may eventually be diagnosed with
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0129_07-13-2009.pdf
    January 01, 2009 - scan of the literature for randomized, controlled, and observational trials published in the last ten years
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
    February 10, 2010 - The final proposed KQs for this review are: Question 1 In adults and children 5 years of age … Question 2 In adults and children 5 years of age and older with asthma, does the use of breathing … PICOTS Population • Adults and children 5 years of age and older with asthma of any type or severity … with asthma of any type and severity, symptomatic or using asthma medication  Children >5 years … diagnosis by medical practitioner (self-report of physician diagnosis acceptable)  Children <5 years
  10. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
    October 01, 2006 - ; the majority of published studies on stent placement in ARAS had followup duration of less than 2 years … differences in mortality rates, no differences in mortality were found between interventions, up to about 5 years … Very high mortality rates, over 40 percent within 6 years, occurred mostly in studies of patients with … single cohort study of medical treatment reported change in serum creatinine over an average of 1.5 years … , and 31 cohort studies of various interventions suggest no difference in mortality up to about 5 years
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
    May 01, 2008 - Together with influenza, pneumonia constitutes the fifth leading cause of death in those age 65 years … The incidence of hospitalization for pneumonia for those age 65 years and older in the US increased … case-control study was nested) was all up-to-standard person-time occurring in individuals age 65 years … Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, … of hospitalization for pneumonia Cases (N = 12,044) Controls (N = 48,176) median age in years
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
    May 18, 2011 - better than not screening for CRC and that the age to begin screening in average-risk adults is 50 years … Force (USPSTF), agree that the recommended options in screening for CRC include: colonoscopy every 10 years … testing (FOBT) or fecal immunohistochemical testing (FIT) annually; and flexible sigmoidoscopy every 5 years … PICOTS Population Asymptomatic adults at average risk for CRC, who are age 40 years or older ( … Inclusion/Exclusion criteria Category Inclusion/Exclusion Criteria Population KQs 1-6: Adults ≥40 years
  13. effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - system is intended to identify interventions that purport to address an unmet need and are up to 3 years … out on the horizon and then to follow them up to 2 years after initial entry into the health care … Topics eligible for inclusion are those interventions expected to be within 0–3 years of potential … its student health center in 2010, charging $25 for each dose of Plan B One-Step® for students 17 years … health center in 2010, charging $25 for each dose of Plan B One-Step® (levonorgestrel) for students 17 years
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
    April 11, 2011 - National Health and Nutrition Examination Surveys in 2005– 2006 estimated that 29 percent of all adults 18 years … Vasan and colleagues report a lifetime risk of developing hypertension within adults aged 55–65 years … • Studies must evaluate adherence rates based on predictors (e.g., age group ≥65 vs. <65 years old … ), not predictor values based on adherence (e.g., adherers were on average X years old and nonadherers … were on average Y years old).
  15. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
    January 01, 2012 - system is intended to identify interventions that purport to address an unmet need and are up to 7 years … out on the horizon and then to follow them for up to 2 years after initial entry into the health care … Topics eligible for inclusion are those interventions expected to be within 0 to 4 years of potential … Buprenorphine falls into the Schedule III class of drugs under the Controlled Substances Act of 1970. 6 For years … a health systems perspective, noted that the injection, which has been on the market for several years
  16. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - Its prevalence increases with age, from 0.1 percent in people under 55 years to more than 9 percent by … 80 years of age. … There is a high level of evidence to show that age, within the approximate range of 40 to 70 years, is … suggest that only a small proportion of patients included in the analyses were younger than about 40 years … or older than about 70 years.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
    March 01, 2011 - Among Medicare beneficiaries age 85 years or older, sulfonylureas were used more frequently than both … It is strongly associated with obesity and age over 45 years. … a sulfonylurea, compared with a low of less than 18 percent of beneficiaries under the age of 45 years … The years were chosen based on the availability of Medicare Part D in 2006.
  18. effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - system is intended to identify interventions that purport to address an unmet need and are up to 7 years … out on the horizon and then to follow them for up to 2 years after initial entry into the health care … Topics eligible for inclusion are those interventions expected to be within 0–4 years of potential
  19. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - system is intended to identify interventions that purport to address an unmet need and are up to 3 years … out on the horizon and then to follow them up to 2 years after initial entry into the health care … Topics eligible for inclusion are those interventions expected to be within 0–3 years of potential … Patients with IPF have a median life expectancy of 2–3 years from initial diagnosis, and no approved … the ASCEND trial and another phase III trial suggest that pirfenidone’s benefit continued after 2 years
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
    February 01, 2012 - Public Comment - David Ahlquist Executive Summary Comment ES 3-T3-2 ….Persons 65 years of age and … Public Comment - Barry Berger Executive Summary Comment ES 3-T3-2: ….Persons 65 years of age and … This test is expected to be available within the next couple of years. … Evidence for optimal screening intervals is generated over years of clinical experience with newly … This test is expected to be available within the next couple of years.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: